Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from COR

Is Cencora Stock Underperforming the Nasdaq?

Cencora has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

RBI accepts 2 core investment companies' applications for surrendering registration

The Reserve Bank of India has cancelled registration certificates for several non-banking financial companies and core investment companies. This action follows surrender requests from entities like RR Holdings and Anjali Capfin. HDFC Holdings' certificate was cancelled as it is no longer a legal entity post-merger. Other companies surrendered their certificates…

The Economic Times

Are Wall Street Analysts Bullish on Cencora Stock?

Cencora has consistently outperformed the broader market over the past year, and analysts are maintaining a strongly bullish outlook on the company’s growth and earnings potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

S&P 500 and Nasdaq 100 at Record Highs on Tech Earnings and US-Iran Peace Hopes

The S&P 500 Index ($SPX ) (SPY ) today is up +1.19%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.44%. June E-mini S&P futures (ESM26 ) are up +1.19%, and June E-mini Nasdaq futures...

Barchart

S&P 500 and Nasdaq 100 Post Record Highs on Tech Strength

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.31%. June E-mini S&P futures (ESM26 ) rose +0.82%, and June E-mini Nasdaq futures...

Barchart

What You Need to Know Ahead of Cencora's Earnings Release

Cencora is scheduled to report its second-quarter results next month, and analysts project a single-digit increase in earnings.

Barchart

Is Cencora Stock Outperforming the S&P 500?

Due to Cencora's outperformance relative to the broader S&P 500 Index, Wall Street analysts remain strongly optimistic about the stock’s outlook.

Barchart

Read news from The Economist, FT, and more,
with one subscription

What to Expect From Cencora's Next Quarterly Earnings Report

Cencora is set to report its first-quarter earnings next month, and analysts are anticipating a single-digit increase in its bottom line.

Barchart

How Is Cencora’s Stock Performance Compared to Other Medical Stocks?

While Cencora’s recent performance has lagged behind other healthcare stocks, analysts express strong confidence in its long-term growth potential.

Barchart

Melbourne-based startup Cor raises US $2 million to bring AI video onboarding to enterprise software

Melbourne-founded startup Cor announced that it has secured US $2 million in a pre-seed funding round to support development of its flagship product, Obi — a generative-video-AI agent designed to guide users through new software via an interactive, personalised onboarding experience.

inkl

Cencora Stock: Is Wall Street Bullish or Bearish?

Pharma distributor Cencora has continued to outpace the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

Barchart

Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday?

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing another interest rate cut.

Benzinga

What to Expect From Cencora's Q4 2025 Earnings Report

Cencora is scheduled to release its fourth-quarter results next month, with analysts projecting double-digit earnings growth.

Barchart

EXCLUSIVE: Worksport Reports Record Q3 Revenue, Gross Profit

Worksport (NASDAQ:WKSP) on Thursday announced its unaudited top-line results for the third quarter of 2025, reporting record quarterly revenue and gross profit.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Cencora Stock: Is COR Outperforming the Health Care Sector?

Cencora has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

Benzinga

Bitcoin, XRP Treasury Strategy Paying Off? Worksport Reports Record Sales

Worksport Ltd. (NASDAQ:WKSP), which earlier this year adopted Bitcoin (CRYPTO: BTC) and Ripple (CRYPTO: XRP) as part of its corporate treasury, reported on Tuesday that it reached a 31% gross margin in July, one quarter ahead of its year-end target.

Barchart

Cencora Stock: Analyst Estimates & Ratings

Cencora has outpaced the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.

Benzinga

Wall Street Recovers, Apple Rallies 6% On $100-Billion Gov Manufacturing Investment: What's Moving Markets Wednesday?

U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook

Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion.

Barchart

Here's What to Expect From Cencora's Next Earnings Report

Cencora is scheduled to release its second-quarter results next month, with analysts projecting double-digit earnings growth.

Barchart

Is Cencora Stock Outperforming the Dow?

Due to Cencora’s strong performance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Cencora Stock?

Cencora has significantly outperformed the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

Barchart

Earnings Preview: What To Expect From Cencora's Report

Cencora is scheduled to report its second-quarter results next month, with analysts projecting a single-digit earnings growth.

Barchart

This ‘Recession-Proof’ Stock Just Set New Highs and Is Flashing ‘Buy’ Signals

Drug stocks like Cencora tend to be recession-proof, making today’s Chart of the Day especially relevant following a tariffs-driven selloff.

Barchart

Is Cencora Stock Outperforming the Nasdaq?

As Cencora has outperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

1 2

People

Abbas Araghchi

817 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.